Page last updated: 2024-11-05

tulobuterol and Breathlessness

tulobuterol has been researched along with Breathlessness in 3 studies

Research Excerpts

ExcerptRelevanceReference
"In COPD patients, additional administration of transdermal tulobuterol to inhaled tiotropium produced significant benefits in dyspnea and SGRQ score as well as pulmonary function."5.14Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD. ( Fukuchi, Y; Ichinose, M; Kubo, K; Mishima, M; Nagai, A; Nishimura, M; Seyama, K, 2010)
" We examined the effect of adding a long-acting anti-cholinergic agent (tiotropium) to a transdermal-type beta(2)-agonist (tulobuterol) on dyspnea as well as pulmonary function."5.12Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist. ( Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Maeda, S; Matsunaga, K; Minakata, Y; Miura, K; Nakanishi, M; Takahashi, T; Ueshima, K; Yamagata, T; Yamagata, Y; Yanagisawa, S, 2007)
"Treatment of COPD patients with TP is more effective than with theophylline."2.73Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline. ( Aizawa, H; Gohara, R; Ichiki, M; Iwanaga, T; Kawayama, T; Kinoshita, M; Koga, H; Minami, S; Nishiyama, M; Sueyasu, Y, 2008)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichinose, M2
Seyama, K1
Nishimura, M1
Fukuchi, Y1
Nagai, A1
Mishima, M1
Kubo, K1
Akamatsu, K1
Yamagata, T1
Takahashi, T1
Miura, K1
Maeda, S1
Yamagata, Y1
Ichikawa, T1
Yanagisawa, S1
Ueshima, K1
Hirano, T1
Nakanishi, M1
Matsunaga, K1
Minakata, Y1
Minami, S1
Kawayama, T1
Ichiki, M1
Nishiyama, M1
Sueyasu, Y1
Gohara, R1
Kinoshita, M1
Koga, H1
Iwanaga, T1
Aizawa, H1

Trials

3 trials available for tulobuterol and Breathlessness

ArticleYear
Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
    Respiratory medicine, 2010, Volume: 104, Issue:2

    Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Bronchodilator Agents; Dose-Response Re

2010
Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist.
    Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:6

    Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-Agonists; Aged; Bronchodilato

2007
Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline.
    Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:6

    Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Aged, 80 and over; Bronchodilator Agent

2008